Sign in Subscribe
Petroleum

US President Trump Announces Tariff Hike on Indian Goods and Services

Strategic Insights

— 1 min read

US President Donald Trump declared on Tuesday that he would be increasing tariffs "very substantially" beyond the initial 25% on Indian goods and services. Trump stated that India's high tariffs were a "sticking point" in their trade deal and accused India of fueling the war machine in Russia by buying Russian oil. The US President also announced a tariff hike on pharmaceutical imports, which will initially be a small tariff but increase to 150% and then 250% over the next one and a half years.

Key Takeaways:

  • US President Donald Trump announced a tariff hike on Indian goods and services, increasing the initial 25% to an unspecified higher rate.
  • India's high tariffs are the "sticking point" in the US-India trade deal, according to Trump.
  • Trump accused India of fueling the war machine in Russia by buying Russian oil, despite India's dependency on Russian oil imports.
  • The US President announced a tariff hike on pharmaceutical imports, which will increase from a small tariff to 150% and then 250% over one and a half years.
  • India's pharmaceutical industry, which employs over 2.7 million people, will be severely impacted by the new tariffs, with exports valued at approximately $9 billion to $10.5 billion annually.
  • Experts predict that the imposition of tariffs will lead to short-term volatility in the Indian pharmaceutical industry, as companies seek to diversify into other markets.
  • Namit Joshi, chairman of Pharmexcil, estimates that it could take three to five years for the Indian pharmaceutical industry to adapt to the new tariffs.

Statistics:

  • $9 billion to $10.5 billion: The annual value of India's pharmaceutical exports to the US.
  • 31%: The percentage of India's total pharmaceutical exports accounted for by the US market.
  • 2.7 million: The number of people employed in India's pharmaceutical industry, which will be severely impacted by the new tariffs.
  • 1.5 years: The maximum timeframe for the tariff hike on pharmaceutical imports to increase from 150% to 250%.
  • $20-25 billion: Estimated annual value of Indian oil imports from Russia.

Sources:

  • CNBC (August 7, 2022): US President Donald Trump's Statement
  • Indian National Press (Bombay) Pvt. Ltd. (no date): MEA Spokesperson Randhir Jaiswal's Statement
  • X (no date): Michael Kugelman's statement
  • Contify.com (no date): Former Foreign Secretary Kanwal Sibal's Statement

Read more